FdaApplication
ANDA 210040
Identifiers
- fda_app_no: ANDA210040
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS OF NEW YORK LLC |
| application_type | ANDA |
| approval_date | 2017-12-22 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| METHOTREXATE SODIUM | METHOTREXATE SODIUM | EQ 2.5MG BASE | TABLET;ORAL |
1 product